Drug Shortage Report for APO-VALSARTAN/HCTZ
Report ID | 263 |
Drug Identification Number | 02382555 |
Brand name | APO-VALSARTAN/HCTZ |
Common or Proper name | VALSARTAN/HCTZ |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
Strength(s) | 12.5MG 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL & 30 BLS |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-01-04 |
Estimated end date | |
Actual end date | 2018-12-28 |
Shortage status | Resolved |
Updated date | 2019-03-21 |
Company comments | |
Health Canada comments | |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.